These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Novel Patents Targeting Interleukin-17A; Implications in Cancer and Inflammation. Santibanez JF; Bjelica S Recent Pat Anticancer Drug Discov; 2018; 13(2):133-144. PubMed ID: 29468982 [TBL] [Abstract][Full Text] [Related]
3. IL-17 in lung disease: friend or foe? Tan HL; Rosenthal M Thorax; 2013 Aug; 68(8):788-90. PubMed ID: 23604380 [TBL] [Abstract][Full Text] [Related]
4. Neutralization of interleukin-17A delays progression of silica-induced lung inflammation and fibrosis in C57BL/6 mice. Chen Y; Li C; Weng D; Song L; Tang W; Dai W; Yu Y; Liu F; Zhao M; Lu C; Chen J Toxicol Appl Pharmacol; 2014 Feb; 275(1):62-72. PubMed ID: 24291675 [TBL] [Abstract][Full Text] [Related]
5. IL-17A deficiency mitigates bleomycin-induced complement activation during lung fibrosis. Cipolla E; Fisher AJ; Gu H; Mickler EA; Agarwal M; Wilke CA; Kim KK; Moore BB; Vittal R FASEB J; 2017 Dec; 31(12):5543-5556. PubMed ID: 28821630 [TBL] [Abstract][Full Text] [Related]
6. Neutrophils, interleukin-17A and lung disease. Lindén A; Laan M; Anderson GP Eur Respir J; 2005 Jan; 25(1):159-72. PubMed ID: 15640338 [TBL] [Abstract][Full Text] [Related]
7. [Blocking IL-17A protects against lung injury-induced pulmonary fibrosis through promoting the activation of p50NF-kappaB]. Mi S; Li Z; Liu H; Hu ZW; Hua F Yao Xue Xue Bao; 2012 Jun; 47(6):739-44. PubMed ID: 22919721 [TBL] [Abstract][Full Text] [Related]
8. The IL-17A/IL-17RA axis in pulmonary defence and immunopathology. Lorè NI; Bragonzi A; Cigana C Cytokine Growth Factor Rev; 2016 Aug; 30():19-27. PubMed ID: 27033174 [TBL] [Abstract][Full Text] [Related]
9. The IL-17 pathway as a major therapeutic target in autoimmune diseases. Hu Y; Shen F; Crellin NK; Ouyang W Ann N Y Acad Sci; 2011 Jan; 1217():60-76. PubMed ID: 21155836 [TBL] [Abstract][Full Text] [Related]
10. Innate cellular sources of interleukin-17A regulate macrophage accumulation in cigarette- smoke-induced lung inflammation in mice. Bozinovski S; Seow HJ; Chan SP; Anthony D; McQualter J; Hansen M; Jenkins BJ; Anderson GP; Vlahos R Clin Sci (Lond); 2015 Nov; 129(9):785-96. PubMed ID: 26201093 [TBL] [Abstract][Full Text] [Related]
12. IL-17A Is Critical for CD8+ T Effector Response in Airway Epithelial Injury After Transplantation. Zhang R; Fang H; Chen R; Ochando JC; Ding Y; Xu J Transplantation; 2018 Dec; 102(12):e483-e493. PubMed ID: 30211827 [TBL] [Abstract][Full Text] [Related]
13. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis. Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756 [TBL] [Abstract][Full Text] [Related]
14. Role of neutralizing anti-murine interleukin-17A monoclonal antibody on chronic ozone-induced airway inflammation in mice. Zhang M; Fei X; Zhang GQ; Zhang PY; Li F; Bao WP; Zhang YY; Zhou X Biomed Pharmacother; 2016 Oct; 83():247-256. PubMed ID: 27380433 [TBL] [Abstract][Full Text] [Related]
15. The role of interleukin-17A in the pathogenesis of kidney diseases. Cortvrindt C; Speeckaert R; Moerman A; Delanghe JR; Speeckaert MM Pathology; 2017 Apr; 49(3):247-258. PubMed ID: 28291548 [TBL] [Abstract][Full Text] [Related]
16. The role of recipient derived interleukin-17A in a murine orthotopic lung transplant model of restrictive chronic lung allograft dysfunction. Yamada Y; Vandermeulen E; Heigl T; Somers J; Vaneylen A; Verleden SE; Bellon H; De Vleeschauwer S; Verbeken EK; Van Raemdonck DE; Vos R; Verleden GM; Jungraithmayr W; Vanaudenaerde BM Transpl Immunol; 2016 Nov; 39():10-17. PubMed ID: 27737799 [TBL] [Abstract][Full Text] [Related]
17. IL-17A Blockade Attenuates Obliterative Bronchiolitis and IFN-γ Cellular Immune Response in Lung Allografts. Gupta PK; Wagner SR; Wu Q; Shilling RA Am J Respir Cell Mol Biol; 2017 Jun; 56(6):708-715. PubMed ID: 28118023 [TBL] [Abstract][Full Text] [Related]
18. IL-17A blockade or deficiency does not affect progressive renal fibrosis following renal ischaemia reperfusion injury in mice. Thorenz A; Völker N; Bräsen JH; Chen R; Jang MS; Rong S; Haller H; Kirsch T; Vieten G; Klemann C; Gueler F J Pharm Pharmacol; 2017 Sep; 69(9):1125-1135. PubMed ID: 28573734 [TBL] [Abstract][Full Text] [Related]
19. Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10/STAT3-suppressed autophagy in hepatocytes. Zhang XW; Mi S; Li Z; Zhou JC; Xie J; Hua F; Li K; Cui B; Lv XX; Yu JJ; Hu ZW Oncotarget; 2017 Feb; 8(6):9922-9934. PubMed ID: 28039485 [TBL] [Abstract][Full Text] [Related]
20. IL-17A Is Elevated in End-Stage Chronic Obstructive Pulmonary Disease and Contributes to Cigarette Smoke-induced Lymphoid Neogenesis. Roos AB; Sandén C; Mori M; Bjermer L; Stampfli MR; Erjefält JS Am J Respir Crit Care Med; 2015 Jun; 191(11):1232-41. PubMed ID: 25844618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]